drugset / Trial / NCT01122602

Evaluate Analgesic Efficacy of Fast Release Aspirin

NCT01122602

Phase 3 Completed 500 enrolled Bayer
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of the study is to evaluate the analgesic efficacy of a single, oral dose of fast release aspirin tablets, 650 mg (2 x 325 mg) compared to regular aspirin tablets, 650 mg (2 x 325 mg) and placebo in subjects with postsurgical dental pain.

Timeline

Start
2010-04-29
Primary completion
2010-07-29
Completion
2010-08-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetylsalicyclic acid Unknown 650 mg Oral

Indications

No indication recorded.